FOLH1 and neoplasm: These synthetic advantages in terms of radiolabeling and stability are accompanied by good binding affinities in vitro and excellent PSMA-specific internalization in LNCaP tumor cells, which correspond with those of the radiolabeled PSMA-617 versions.